Unique ID issued by UMIN | UMIN000049619 |
---|---|
Receipt number | R000056447 |
Scientific Title | A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients |
Date of disclosure of the study information | 2022/11/26 |
Last modified on | 2024/12/05 11:53:43 |
A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients
DIET-ICI study
A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients
DIET-ICI study
Japan |
Non-small cell lung cacner
Pneumology |
Malignancy
NO
To clarify the impact of diet on the efficacy of immune checkpoint inhibitorsin patients with non-small cell lung cancer
Others
To clarify the correlation between various blood amino acid and fatty acid levels and the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patient
Exploratory
Pragmatic
Not applicable
Progression-free survival
1) Objective response rate
2) Overall survival
3) Immune-related adverse events
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients with histologically or cytologically diagnosed non-small cell lung cancer
2. Patients who receive treatment including immune checkpoint inhibitors (monotherapy or combination therapy) as initial therapy (However, patients with driver gene mutations who have previously been treated with molecular targeted drugs are also acceptable)
3. Patients with her PS 0-2 at enrollment
4. Patients with self-determination ability over 20 years old
5. Patients with written consent
1. Patients under the age of 20
2. Patients who cannot consent to participate in this study
3. Patients who have insufficient decision-making ability and cannot obtain written informed consent from the patient
4. Patients who are judged to be inappropriate as research subjects by the principal investigator or co-investigator
120
1st name | Takuro |
Middle name | |
Last name | Sakagami |
Kumamoto University Medical Sciences
Department of Respiratory Medicine
860-8556
1-1-1 Honjo, Chuoh-Ku, Kumamoto City, Japan
096-373-5012
stakuro@kumamoto-u.ac.jp
1st name | Koichi |
Middle name | |
Last name | Saruwatari |
Kumamoto University Medical Sciences
Department of Respiratory Medicine
860-8556
1-1-1 Honjo, Chuoh-Ku, Kumamoto City, Japan
096-373-5012
ksaruwat@kuh.kumamoto-u.ac.jp
Department of Respiratory Medicine Kumamoto University Medical Sciences
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Faculty of Life Sciences, Kumamoto University
1-1-1 Honjo, Chuo-ku, Kumamoto
096-373-5657
ski-shien@jimu.kumamoto-u.ac.jp
NO
熊本中央病院(熊本県),熊本市民病院(熊本県)、くまもと県北病院(熊本県)、熊本労災病院(熊本県)、人吉医療センター(熊本県)、宮崎県立延岡病院(宮崎県)
2022 | Year | 11 | Month | 26 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 09 | Month | 23 | Day |
2022 | Year | 10 | Month | 27 | Day |
2022 | Year | 11 | Month | 28 | Day |
2026 | Year | 03 | Month | 31 | Day |
The information of diet in non-small cell lung cancer patients receiving immune checkpoint inhibitors is collected using a food intake frequency questionnaire. We investigate the clinical course after the administration immune checkpoint inhibitors in NSCLC patients who was entried this study.
2022 | Year | 11 | Month | 26 | Day |
2024 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056447